Higher expression of XPF is a critical factor in intrinsic chemotherapy resistance of human renal cell carcinoma

Similar cisplatin sensitivity of HPV-positive and -negative HNSCC cell lines

(2016) Chia-Jung Busch et al.   Oncotarget

XPF protein levels determine sensitivity of malignant melanoma cells to oxaliplatin chemotherapy: Suitability as a biomarker for patient selection

(2013) Stephanie B. Hatch et al.   INTERNATIONAL JOURNAL OF CANCER

Multiple DNA Binding Domains Mediate the Function of the ERCC1-XPF Protein in Nucleotide Excision Repair

(2012) Yan Su et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

XPG and XPF Endonucleases Trigger Chromatin Looping and DNA Demethylation for Accurate Expression of Activated Genes

(2012) Nicolas Le May et al.   MOLECULAR CELL

DNA repair endonuclease ERCC1-XPF as a novel therapeutic target to overcome chemoresistance in cancer therapy

(2012) E. M. McNeil et al.   NUCLEIC ACIDS RESEARCH

Defective transcription initiation causes postnatal growth failure in a mouse model of nucleotide excision repair (NER) progeria

(2012) I. Kamileri et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Role of Endonucleases XPF and XPG in Nucleotide Excision Repair of Platinated DNA and Cisplatin/Oxaliplatin Cytotoxicity

(2011) Nora Graf et al.   CHEMBIOCHEM

Killing of Chronic Lymphocytic Leukemia by the Combination of Fludarabine and Oxaliplatin Is Dependent on the Activity of XPF Endonuclease

(2011) A. Zecevic et al.   CLINICAL CANCER RESEARCH

XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and Neck

(2011) Alec Vaezi et al.   CLINICAL CANCER RESEARCH

Physiological consequences of defects in ERCC1–XPF DNA repair endonuclease

(2011) Siobhán Q. Gregg et al.   DNA REPAIR

Basic Research in Kidney Cancer

(2011) Egbert Oosterwijk et al.   EUROPEAN UROLOGY

ICUD-EAU International Consultation on Kidney Cancer 2010: Treatment of Metastatic Disease

(2011) Jean-Jacques Patard et al.   EUROPEAN UROLOGY

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model

(2011) Derek J. Matoka et al.   PROSTATE

Cisplatin sensitivity of testis tumour cells is due to deficiency in interstrand-crosslink repair and low ERCC1-XPF expression

(2010) Svetlana Usanova et al.   Molecular Cancer

Renal cell carcinoma

(2009) Brian I Rini et al.   LANCET

XPF-ERCC1 Participates in the Fanconi Anemia Pathway of Cross-Link Repair

(2009) N. Bhagwat et al.   MOLECULAR AND CELLULAR BIOLOGY

Cdk1 Participates in BRCA1-Dependent S Phase Checkpoint Control in Response to DNA Damage

(2009) Neil Johnson et al.   MOLECULAR CELL

Human XPF controls TRF2 and telomere length maintenance through distinctive mechanisms

(2008) Yili Wu et al.   MECHANISMS OF AGEING AND DEVELOPMENT

ERCC1-XPF Endonuclease Facilitates DNA Double-Strand Break Repair

(2008) A. Ahmad et al.   MOLECULAR AND CELLULAR BIOLOGY

Elevated Glutathione Levels Confer Cellular Sensitization to Cisplatin Toxicity by Up-Regulation of Copper Transporter hCtr1

(2008) H. H. W. Chen et al.   MOLECULAR PHARMACOLOGY

The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy

(2007) Matthew D. Hall et al.   Annual Review of Pharmacology and Toxicology